HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A correction has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mummery, R. S. Articles by Rider, C. C. Search for Related Content PubMed PubMed Citation Articles by Mummery, R. S. Articles by Rider, C. C.

Characterization of the Heparin-Binding Properties of IL-6¹

Division of Biochemistry, Royal Holloway University of London, Egham, Surrey, United Kingdom

We establish, using an ELISA approach, that recombinant human and murine IL-6 bind to an immobilized heparin-BSA complex. In the case of human IL-6, this binding is displaceable by soluble heparin, IC₅₀ 2 µg/ml, corresponding to 200 nM. This binding is specific because chondroitin sulfates B and C fail to compete, whereas chondroitin sulfate A and several heparan sulfates are weak inhibitors. Of a range of chemically modified heparins examined, the strongest competitor was the 2-O-desulfated product, but even this showed a considerably reduced IC₅₀ (30 µg/ml). The epitopes of five IL-6-specific mAbs were still accessible in heparin-bound IL-6, and the dimer formed from the association of rIL-6 with its truncated soluble receptor polypeptide, srIL-6, still bound to heparin. Further analysis showed that heparin competed partially and weakly with the binding of srIL-6 to IL-6; however, it competed strongly for the binding of the rIL-6/srIL-6R dimer, to soluble glycoprotein 130. In studies of the proliferation of IL-6-sensitive Ba/F3 cells expressing glycoprotein 130, we were unable to detect any effect of either the removal of cell surface heparan sulfate, or addition of soluble heparin. By contrast, heparin was able to protect IL-6 from digestion by the bacterial endoproteinase Lys-C. Overall, our findings show that IL-6 is a heparin-binding cytokine. This interaction will tend to retain IL-6 close to its sites of secretion in the tissues by binding to heparin-like glycosaminoglycans, thus favoring a paracrine mode of activity. Moreover, this binding may serve to protect the IL-6 from proteolytic degradation.

This article has been cited by other articles:

				M. Ishii and N. Maeda Spatiotemporal expression of chondroitin sulfate sulfotransferases in the postnatal developing mouse cerebellum Glycobiology, August 1, 2008; 18(8): 602 - 614. [Abstract] [Full Text] [PDF]

				K. Hayashida, Y. Chen, A. H. Bartlett, and P. W. Park Syndecan-1 Is an in Vivo Suppressor of Gram-positive Toxic Shock J. Biol. Chem., July 18, 2008; 283(29): 19895 - 19903. [Abstract] [Full Text] [PDF]

				A. Sainsbury, R. A. Goodlad, S. L. Perry, S. G. Pollard, G. G. Robins, and M. A. Hull Increased Colorectal Epithelial Cell Proliferation and Crypt Fission Associated with Obesity and Roux-en-Y Gastric Bypass Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1401 - 1410. [Abstract] [Full Text] [PDF]

				N. Sasaki, K. Okishio, K. Ui-Tei, K. Saigo, A. Kinoshita-Toyoda, H. Toyoda, T. Nishimura, Y. Suda, M. Hayasaka, K. Hanaoka, et al. Heparan Sulfate Regulates Self-renewal and Pluripotency of Embryonic Stem Cells J. Biol. Chem., February 8, 2008; 283(6): 3594 - 3606. [Abstract] [Full Text] [PDF]

				R. S Mummery, B. Mulloy, and C. C Rider The binding of human betacellulin to heparin, heparan sulfate and related polysaccharides Glycobiology, October 1, 2007; 17(10): 1094 - 1103. [Abstract] [Full Text] [PDF]

				M. Strazynski, J. A. Eble, H. Kresse, and E. Schonherr Interleukin (IL)-6 and IL-10 Induce Decorin mRNA in Endothelial Cells, but Interaction with Fibrillar Collagen Is Essential for Its Translation J. Biol. Chem., May 14, 2004; 279(20): 21266 - 21270. [Abstract] [Full Text] [PDF]

				S. M. Rickard, R. S. Mummery, B. Mulloy, and C. C. Rider The binding of human glial cell line-derived neurotrophic factor to heparin and heparan sulfate: importance of 2-O-sulfate groups and effect on its interaction with its receptor, GFR{alpha}1 Glycobiology, June 1, 2003; 13(6): 419 - 426. [Abstract] [Full Text] [PDF]

				M. Iqbal and J. W. McCauley Identification of the glycosaminoglycan-binding site on the glycoprotein Erns of bovine viral diarrhoea virus by site-directed mutagenesis J. Gen. Virol., September 1, 2002; 83(9): 2153 - 2159. [Abstract] [Full Text] [PDF]

				T. Vincent, M. Jourdan, M.-S. Sy, B. Klein, and N. Mechti Hyaluronic Acid Induces Survival and Proliferation of Human Myeloma Cells through an Interleukin-6-mediated Pathway Involving the Phosphorylation of Retinoblastoma Protein J. Biol. Chem., April 27, 2001; 276(18): 14728 - 14736. [Abstract] [Full Text] [PDF]

				B. T. Seet, J. Barrett, J. Robichaud, B. Shilton, R. Singh, and G. McFadden Glycosaminoglycan Binding Properties of the Myxoma Virus CC-chemokine Inhibitor, M-T1 J. Biol. Chem., August 3, 2001; 276(32): 30504 - 30513. [Abstract] [Full Text] [PDF]